Trial
NCT01378377
Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
EMD Serono
Collaborators
—
Condition
Advanced Solid Tumor
Intervention
Pimasertib
Why stopped
The trial was stopped due to the toxicities observed with the combination of pimasertib and temsirolimus.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-30